IGF1R and Barrett esophagus: Frequency: It has been demonstrated that there is an increased pIRS1 staining (IGF1R activation marker) in 43.2% of BE patients and 70% of EAC patients, a phenomenon that implies the significant effect of IGF1R in BE progression towards dysplasia and EAC [158].